Diligence memo · auto-generated · as of July 3, 2026
Tamarind Bio, Inc.
Tamarind Bio, Inc. has raised $14M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
Tamarind Bio, Inc. operates in Biotech, based in SAN FRANCISCO, CA, USA. AI Inference Platform for Drug Discovery
Sub-sector tags: AI-powered Drug Discovery, Artificial Intelligence, B2B, Biotech, SaaS, ai/ml, devtools, pharma.
Capital & rounds (filed)filed
Tamarind Bio, Inc. has raised $14M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $14M on 2025-05-02.
Most recent recorded round closed around 2025-05-02.
Valuation (modeled)modeled
Provath models Tamarind Bio, Inc. at approximately $48M (range $15M–$85M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 14 mo ago; this sector typically re-raises about every 11 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 87% of Biotech peers (233 compared).
Modeled value ranks above 82% of those peers.
Closest niche peers: CHD Bioscience, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.